Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global...
The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.
Diagnostics and Therapeutics for Autism Spectrum Disorders: Globa...
The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.
Stroke Diagnostics and Therapeutics: Global Markets
The global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019.
Cardiac Equipment: Technologies and Global Markets
The global market for cardiac medical devices was valued at nearly $49.4 billion in 2013 and $52 billion in 2014. This market is projected to reach nearly $67.5 billion by 2019, with a compound annual growth rate (CAGR) of 5.3% from 2014 to 2019.
Incretin-Based Drugs: Markets for Diabetes Therapies and Developi...
The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019.
Therapeutics for 'Silent' Cancers
The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.
Global Markets for Implantable Biomaterials
The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.
U.S. and Global Markets for Ethical Nutrition in Healthcare
The global market for ethical nutrition in healthcare was valued at roughly $34.5 billion in 2013 and increased to $37.1 billion in 2014. This market is expected to reach about $58.2 billion by 2019, with a compound annual growth rate (CAGR) of 9.4% from 2014 to 2019.
Enteric Disease Testing and Treatment: Technologies and Global Ma...
The global market for diagnostics and preventive vaccines for enteric diseases reached $6.5 billion in 2013. This market should grow to $10 billion in 2014 and about $21.9 billion in 2018, a compound annual growth rate (CAGR) of 27.3%.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Ma...
The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to about $610.3 million in 2015 and about $5.4 billion in 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
Global Markets for Nanoparticle Size Analysis Instrumentation in ...
The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Glo...
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
Blood-Brain Barrier Technologies and Global Markets
The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.
Joint Reconstruction and Replacement: Materials, Technologies, an...
The global market for joint reconstruction and replacement was worth nearly $13.2 billion in 2013. This market is expected to increase to nearly $16.2 billion by 2018, registering a compound annual growth rate (CAGR) of 4.2% from 2013 through 2018.
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...
The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.
JAK and PI3K Signaling Pathway Markets
The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.
Drugs for Treating Systemic Lupus Erythematosus: Global Markets
The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.
Peripheral Vascular Surgical Products: Technologies and Global Ma...
The global market for peripheral vascular surgical devices reached $5.8 billion in 2012. This market is projected to grow from $6.2 billion in 2013 to $8.4 billion in 2018 with a compound annual growth rate (CAGR) of 6.3% for the five-year period, 2013 to 2018.
Histone Deacetylase Inhibitors: Emerging Markets
The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.
Drugs for Treating Mental Disorders: Technologies and Global Mark...
The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
2013 Oncology Research Review
This BCC Research review provides highlights from oncology and other related market research reports published in 2013. It covers topics like uterine cancer, ovarian cancer, cervical cancer, prostrate cancer, and hematological disorders.
Global Markets and Technologies for Molecular Imaging Devices
The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.
Biomarkers: Technologies and Global Markets
This report offers an in-depth analysis of the global biomarkers market, including market forecasts and sales projections through 2029. It examines the market by segmenting it into various product categories.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
This report comprehensively covers the global OTC drugs, medical devices, and diagnostics market, presenting quantitative and qualitative data.
Softgel Capsules: Global Markets
This report provides a detailed overview of the softgel capsules market.
Rare Disease Diagnostics: Technologies and Global Markets
This report provides an overview of rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2023 and 2024, and then forecast through 2029.
Medical Devices Industry: Competitive Landscape
This report provides an overview of the medical device market and its competitive landscape.
Global DNA Sequencing: Research, Applied and Clinical Markets
This report aims to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for DNA sequencing. Important trends are identified, and sales forecasts by technology, product & services, end-user, application, and disease category are provided through 2029.
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The report provides an in-depth analysis of the bioprocess optimization and digital biomanufacturing market, including market estimations and trends.
In Vitro Diagnostics: Technologies and Global Markets
This report incorporates an in-depth analysis of the In vitro diagnostics technologies and global markets, including market estimations and trends through 2029. Major players, competitive intelligence, innovative & emerging technologies, market dynamics and regional opportunities are discussed in detail.
Laboratory Animal Models, 3D Cultures and Organoids: Global Markets
This report provides detailed exposure to the laboratory animal model, 3D cell culture and organoids market. This report will highlight current and future market potential and a detailed analysis of the competitive environment.
Breakthrough Therapies: Market Dynamics and Investment Opportunities
This report provides an overview of the current regulatory environment, possible applications for breakthrough therapy designation (BTD) in other parts of the world, and ways to combine BTD with early access to medication programs to enhance patient access to medication for the treatment of rare diseases and high unmet clinical needs.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report provides an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2023.
High-Throughput Screening: Technologies and Global Markets
This report provides an analysis of the global high-throughput screening (HTS) market. It includes major market dynamics and current trends within the industry.
Global Injectable Drug Delivery Devices Market
This report provides a comprehensively study the market size of injectable drug delivery devices.
Tissue Diagnostics: Technologies and Global Markets
This report provides a comprehensive analysis of the global market for tissue diagnostics and technologies.
Biosimilars: Global Markets
This report provides a complete review and analysis of the current biosimilars market and industry growth drivers and challenges.
Surgical Equipment: Technologies and Global Markets
This research report comprehensively analyzes the surgical equipment market, including forecasts and sales projections through 2029. It covers key market players, detailed product segments, supporting technologies, trends, market dynamics, competitive intelligence, and regional trends.
Biologic and Medical Imaging Reagents: Global Markets
This report includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials; fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are included in this report.
Medical Imaging: A BCC Research Outlook
This report covers various types of products available in the medical imaging instruments market and potential application sectors across various industries.
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
This report encompasses the global and regional markets for Alzheimer’s therapeutics and diagnostics.
Global Colorectal Cancer Screening and Diagnostics Market
This report provides the current market scenario for colorectal cancer screening and diagnostics and assess the market's growth potential from 2024 through 2029. The study aims to estimate the size of the colorectal cancer screening and diagnostics market at both global and regional levels.
Cell-Based Assays: Technologies and Global Markets
This report provides an in-depth analysis of the global cell-based assays technologies market, segmented by product type, application, and end user. The applications include drug discovery for validating drug targets, lead profiling assays, absorption, distribution, metabolism, and excretion (ADME) toxicity assays, and basic research.
Global Markets for Emerging Medical Device Technologies
This report provides an in-depth analysis of the global markets for emerging medical device technologies, including market estimations and forecasts through 2029.
High Content Screening/Imaging: Technologies and Global Markets
This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The report provides an overview of the industry structure and its competitive landscape of the market for liquid biopsy research tools, services and diagnostics. It covers market projections through 2029.
Global Diabetic Care Devices Market
This report provides an analysis of the global diabetes care devices market, with market projections through 2029.
Neurology Market: A BCC Research Overview
This report covers therapeutics used in the treatment of neurological disorders. It highlights the current and future market potential of neurology medicines.